References
- Seibold F, Slametschka D, Gregor M, Weber P. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1994; 107: 532–6
- Ward M. The pathogenesis of Crohn's disease. Lancet 1977; 2: 903–5
- Dell'Isola B, Poyart C, Goulet O, et al. Detection of Mycobacterium paratuberculosis by polymerase chain reaction in children with Crohn's disease. J Infect Dis 1994; 169: 449–51
- Stainsby K J, Lowes J R, Allan R N. Antibodies in Mycobacterium paratuberculosis and nine species of environmental mycobacteria in Crohn's disease and control subjects. Gut 1993; 34: 371–4
- Winslet M C, Allan A, Poxon V, et al. Faecal diversion for Crohn's colitis. A model to study the role of the faecal stream in the inflammatory process. Gut 1994; 35: 236–42
- Smith M S, Wakefield A J. Viral association with Crohn's disease. Ann Med 1993; 25: 557–61
- Rhodes J, Thomas G AO. Smoking-good or bad for inflammatory bowel disease?. Gastroenterology 1994; 106: 807–10
- Wakefield A J, Sawyerr A M, Dhillon A P, et al. Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet 1989; 2: 1057–62
- Brignola C, Cottone M, Pera A, Ardizzone S, Scribano M L, De Franchis R, et al. Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Italian Co-operative Study Group. Gastroenterology 1995; 108: 345–9
- Rutgeerts P, Lofberg R, Malchow H, Lamers C, Olaison G, Jewell D, et al. A comparison of budesonide with prednisolone for active Crohn's disease. N Engl J Med 1994; 331: 842–5
- Greenberg G R, Feagan B G, Martin F, Sutherland L R, Thomson A B, Williams C N, et al. Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group. N Engl J Med 1994; 331: 836–41
- Nygaard K, Bergan T, Bjorneklett A, Hoverstad T, Lassen J, Aase S. Topical metronidazole treatment in pouchitis. Scand J Gastroenterol 1994; 29: 462–7
- Lichtiger S, Present D H, Kornbluth A, Gelernt I, Bauer J, Galler G, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994; 330: 1841–5
- Present D H, Lichtiger S. Efficacy of cyclosporine in treatment of fistula of Crohn's disease. Dig Dis Sci 1994; 39: 374–80
- Campieri M, Paoluzi P, D'Albasio G, Brunetti G, Pera A, Barbara L. Better quality of therapy with 5-ASA colonic foam in active ulcerative colitis: a multicenter comparative trial with 5-ASA enema. Dig Dis Sci 1993; 38: 1843–50
- Yamaguchi T, Sasaki K, Kurosaki Y, Nakayama T, Kimura T. Biopharmaceutical evaluation of salicylazosulfanilic acid as a novel colon-targeted prodrug of 5-aminosalicyclic acid. J Drug Target 1994; 2: 123–31
- Prantera C, Kohn A, Mangiarotti R, Andreoli A, Luzi C. Antimycobacterial therapy in Crohn's disease: results of a controlled, double-blind trial with a multiple antibiotic regimen. Am J Gastroenterol 1994; 89: 513–8
- Pullan R D, Rhodes J, Ganesh S, Mani V, Morris J S, Williams G T, et al. Transdermal nicotine for active ulcerative colitis. N Engl J Med 1994; 330: 811–5
- Moody G A, Mayberry J F. Perceived sexual dysfunction amongst patients with inflammatoiy bowel disease. Digestion 1993; 54: 256–60
- Connell W R, Lennard-Jones J E, Williams C B, Talbot I C, Price A B, Wilkinson K H. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 1994; 107: 934–44
- Redston M S, Papadopoulos N, Caldas C, Kinzler K W, Kern S E. Common occurrence of APC and K-ras gene mutations in the spectrum of colitis-associated neoplasias. Gastroenterology 1995; 108: 383–92
- Ghosh S, Cowen S, Hannan W J, Ferguson A. Low bone mineral density in Crohn's disease, but not in ulcerative colitis at diagnosis. Gastroenterology 1994; 107: 1031–9
- Abitbol V, Roux C, Chaussade S, Guillemant S, Kolta S, Dougados M, et al. Metabolic bone assessment in patients with inflammatory bowel disease. Gastroenterology 1995; 108: 417–22
- McLntyre P B, Pemberton J H, Wolff B G, Beart R W, Dozois R R. Comparing functional results one year and ten years after ileal pouch-anal anastomosis for chronic ulcerative colitis. Dis Colon Rectum 1994; 37: 303–7
- Jorge J M, Wexner S D, Morgado P J, Jr, James K, Nogueras J J, Jagelman D G. Optimization of sphincter function after the ileoanal reservoir procedure. A prospective, randomized trial. Dis Colon Rectum 1994; 37: 419–23
- Nagel E, Bartels M, Pichlmayr R. Scanning electron-microscopic lesions in Crohn's disease: relevance for the interpretation of postoperative recurrence. Gastroenterology 1995; 108: 376–82